Kailera

This study tests a new weekly injection called KAI-9531 in 1700 adults who are overweight or have obesity and type 2 diabetes. The goal is to see if it helps with weight loss and improves blood sugar levels compared to a placebo. Participants must have tried to lose weight before…

This study tests a new weekly injection, KAI-9531, to see if it helps people with obesity lose more weight than the existing drug semaglutide or a placebo. About 1,200 adults with a BMI of 35 or higher who have tried to lose weight before will take part. The main goal is to measu…

This study tests a new weekly injection called KAI-9531 to help people with obesity lose weight. About 250 adults with a BMI of 35 or higher who have tried and failed to lose weight through diet and exercise will receive either the drug or a placebo for 48 weeks. The main goal is…

This study tests a new weekly injection called KAI-9531 to help people with obesity or overweight lose weight. It includes 1,800 adults who do not have diabetes but have weight-related health problems like high blood pressure or sleep apnea. Participants receive either the drug o…

This study tests an experimental daily pill called KAI-7535 to see if it helps people with obesity or overweight lose more weight than a placebo. The trial includes 320 adults who also have at least one weight-related health problem like high blood pressure or sleep apnea. Partic…